Related Experiment Video
Updated: Jul 23, 2026

High Throughput SiRNA Screening for Chloropicrin and Hydrogen Fluoride-Induced Cornea Epithelial Cell Injury
Published on: June 16, 2018
Hydantoin immunosuppression clinical study
A H Badawy1, S A Shalaby, S F Abdel Aal
1Department of Forensic Medicine and Toxicology, Ain Shams University, Cairo.
Abstract:
A study was conducted on 51 epileptic patients divided into two groups. Group 1: 20 patients without anticonvulsant treatment for at least two years, and group II: 31 patients receiving phenytoin in a dose of 300 mg/24 hr for at least 4 months. A group of normal and blood donor subjects were used as control. The serum concentrations of IgA and IgM were significantly decreased in the phenytoin treated patients in comparison with control. Non-treated epileptics showed a significant decrease of IgA level in comparison with control. It was suggested that phenytoin treatment suppresses the normal function of the humoral immune response and that epilepsy may be a contributing factor.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antihypertensive Drugs: Direct Renin Inhibitors
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Therapeutic Drug Monitoring: Affecting Factors
Inhibitors of Viral Protein Synthesis

